Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer

Thyroid

Volumn 13, Issue 5, 2003, Pages 479-484

  Antonelli, Alessandro ^a,b   Miccoli, Paolo ^a   Fallahi, Poupak ^a   Grosso, Mariano ^a   Nesti, Claudia ^a   Spinelli, Claudio ^a   Ferrannini, Ele ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Istituto di Clinica Medica II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LIOTHYRONINE; THYROGLOBULIN; THYROID HORMONE; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; CANCER LOCALIZATION; CERVICAL LYMPH NODE; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; SCHOOL CHILD; THYROGLOBULIN BLOOD LEVEL; THYROID PAPILLARY CARCINOMA; WHOLE BODY SCINTISCANNING;

EID: 0037529279     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072503322021142     Document Type: Article

References (44)

1. Simeone JF, Daniels GH, Hall DA, McCarthy K, Kopans DB, Butch RJ, Mueller PR, Stark DD, Ferrucci JT Jr, Wang CA 1987 Sonography in the follow-up of 100 patients with thyroid carcinoma. AJR Am J Roentgenol 148:45-49.
2. Sutton RT, Reading CC, Charboneau JW, James EM, Grant CS, Hay ID 1988 US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer. Radiology 168:769-772.
3. Antonelli A, Miccoli P, Ferdeghini M, Di Coscio G, Alberti B, Iacconi P, Baldi V, Baschieri L 1995 Role of neck ultrasonography in follow-up of patients operated on for differentiated thyroid cancer. Thyroid 5:25-29.
4. Maxon HR II, Smith HS 1990 Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 19:685-718.
5. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliff SB, Panzarella T 1987 Papillary and follicular thyroid cancer: Prognostic factors in 1578 patients. Am J Med 83:479-488.
6. Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK, O'Sullivan B 1997 A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example. Cancer 79:2414-2423.
7. Hay I Papillary thyroid carcinoma 1990 Endocrinol Metab Clin North Am 19:545-576.
8. Reading CC, Charboneau JW, James EH, Hurt MR 1988 Sonographically guided percutaneous biopsy of small (3 cm or less) masses. AJR Am J Roentgenol 151:189-192.
9. Van den Brekel MW, Castelijns JA, Stel HV, Luth WJ, Valk J, van der Waal I, Snow GB 1991 Occult metastatic neck disease: Detection with US and US-guided FNAC. Radiology 180:457-461.
10. Boland GW, Lee JM, Mueller PR, Mayo-Smith W, Dawson LS, Simeone JF 1993 Efficacy of sonographically guided biopsy of thyroid masses and cervical lymph nodes. AJR Am J Roentgenol 161:1053-1056.
11. Franceschi M, Kusic Z, Franceschi D, Lukinac L, Roncevic S 1996 Thyroglobulin determination, neck ultrasonography and iodine-131 whole body scintigraphy in differentiated thyroid carcinoma. J Nucl Med 37:446-451.
12. King AD, Ahuja AT, To EW, Tse GM, Metreweli C 2000 Staging papillary carcinoma of the thyroid: Magnetic resonance imaging vs. ultrasound of the neck. Clin Radiol 55:222-226.
13. Rubello D, Mazzarotto R, Casara D 2000 The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery. Eur J Nucl Med 27:431-440.
14. Frilling A, Gorges R, Tecklenborg K, Gassmann P, Bockhorn M, Clausen M, Broelsch CE 2000 Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 128:1067-1074.
15. Wunderbaldinger P, Harisinghani MG, Hahn PF, Daniels GH, Turetschek K, Simeone J, O'Neill MJ, Mueller PR 2002 Cystic lymph node metastases in papillary thyroid carcinoma. AJR Am J Roentgenol 178:693-697.
16. Dietlein M, Moka D, Scheidhauer K, Schmidt M, Theissen P, Voth E, Eschner W, Schicha H 2000 Follow-up of differentiated thyroid cancer: Comparison of multiple diagnostic tests. Nucl Med Commun 21:991-1000.
17. Schlumberger M, De Vathaire F, Travagli JP, Vassal G, Lemerle J, Parmentier C, Tubiana M 1987 Differentiated thyroid carcinoma in childhood: Long term follow-up of 72 patients. J Clin Endocrinol Metab 65:1088-1094.
18. Antonelli A, Miccoli P, Derzhitski VE, Panasiuk G, Solovieva N, Baschieri L 1996 Epidemiologic and clinical evaluation of thyroid cancer in children from the Gomel region (Belarus). World J Surg 20:867-871.
19. Pacini F, Vorontsova T, Demidchik EP, Molinaro E, Agate L, Romei C, Shavrova E, Cherstvoy ED, Ivashkevitch Y, Kuchinskaya E, Schlumberger M, Ronga G, Filesi M, Pinchera A 1997 Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: Comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab 82:3563-3569.
20. Farahati J, Parlowsky T, Mader U, Reiners C, Bucsky P 1998 Differentiated thyroid cancer in children and adolescents. Langenbecks Arch Surg 383:235-239.
21. Miccoli P, Antonelli A, Spinelli C, Ferdeghini M, Fallahi P, Baschieri L 1998 Completion total thyroidectomy in children with thyroid cancer secondary to the Chernobyl accident. Arch Surg 133:89-93.
22. La Quaglia MP, Black T, Holcomb GW 3rd, Sklar C, Azizkhan RG, Haase GM, Newman KD 2000 Differentiated thyroid cancer: Clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. J Pediatr Surg 35:955-959.
23. 131I whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy). Clin Endocrinol 13:107-110.
24. Ronga G, Fiorentino A, Paserio E, Signore A, Todino V, Tummarello MA, Filesi M, Baschieri I 1990 Can iodine-131 wholebody scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma? J Nucl Med 31:1766-1771.
25. Samaan NA, Maheshwari YK, Nader S, Hill CS Jr, Schultz PN, Haynie TP, Hickey RC, Clark RL, Goepfert H, Ibanez ML, Litton CE 1983 Impact of therapy for differentiated carcinoma of the thyroid: An analysis of 706 cases. J Clin Endocrinol Metab 56:1131-1138.
26. Akslen LA, Myking AO, Salvesen H, Varhaug JE 1992 Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. Eur J Cancer 29A:44-51.
27. Mazzaferri EL, Young RL 1981 Papillary thyroid carcinoma. A 10 year follow-up. Report of the impact of therapy in 576 patients. Am J Med 70:511-521.
28. Mc Henry CR, Rosen IB, Walfish PG 1991 Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 162:353-356.
29. Beasley NJ, Lee J, Eski S, Walfish P, Witterick I, Freeman JL 2002 Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 128:825-828.
30. Hughes CJ, Shaha AR, Shah JP, Loree TR 1996 Impact of lymph node metastasis in differentiated carcinoma of the thyroid: A matched-pair analysis. Head Neck 18:127-132.
31. Nemec J, Zamrazil V, Pohunkova DR, Zohling S, Zeman V 1986 Some factors influencing the survival of patients with less advanced stages of differentiated thyroid cancer. Endocrinol Exp 20:85-95.
32. Schelfhout LJ, Creutzberg CL, Hamming JF, Fleuren GJ, Smeenk D, Hermans J, van de Velde CJ, Goslings BM 1988 Multivariate analysis of survival in differentiated thyroid cancer: The prognostic significance of the age factor. Eur J Cancer Clin Oncol 24:331-337.
33. MC Conahey WM, Hay ID, Woolner LB, Van Heerden JA, Taylor WF 1986 Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestation, pathologic findings, therapy and outcome. Mayo Clin Proc 61:978-996.
34. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428.
35. Voutilainen PE, Multanen MM, Leppaniemi AK, Haglund CH, Haapiainen RK, Franssila KO 2001 Prognosis after lymph node recurrence in papillary thyroid carcinoma depends on age. Thyroid 11:953-957.
36. Ortiz S, Rodriguez JM, Parrilla P, Perez D, Moreno-Gallego A, Rios A, Soria T 2001 Recurrent papillary thyroid cancer: Analysis of prognostic factors including the histological variant. Eur J Surg 167:406-412.
37. Bellantone R, Lombardi CP, Boscherini M, Ferrante A, Raffaelli M, Rubino F, Bossola M, Crucitti F 1998 Prognostic factors in differentiated thyroid carcinoma: A multivariate analysis of 234 consecutive patients. J Surg Oncol 68:237-241.
38. Schimpff SC 1979 Well differentiated thyroid cancer. Am J Med Sci 278:100-106.
39. Hay ID 1990 Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19:545-546.
40. Muller-Gartner HW, Schneider C 1988 Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer. Cancer 61:976-981.
41. Frankenthaler RA, Sellin RV, Cangir A, Goepfert H 1990 Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg 160:341-343.
42. Balazs G, Gyory F, Lukacs G, Szakall S 1998 Long-term follow-up of node-positive papillary thyroid carcinomas. Langenbecks Arch Surg 383:180-182.
43. Newman KD, Black T, Heller G, Azizkhan RG, Holcomb GW III, Sklar C, Vlamis V, Haase GM, La Quaglia MP 1998 Differentiated thyroid cancer: Determinants of disease progression in patients <21 years of age at diagnosis. A report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg 227:533-541.
44. Harness JK, Thompson NW, McLeod MK, Pasieka JL, Fukuuchi A 1992 Differentiated thyroid carcinoma in children and adolescents. World J Surg 16:547-53.